Company Search:
Advanced Search
Sponsored Links
AstraZeneca PLC - ADR Company Snapshot
AstraZeneca PLC operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other companies in this sector in the United States: Eli Lilly and Company (2018 sales of $24.56 billion of which 48% was Human pharmaceutical products - Endocrin), Teva Pharmaceutical Industries Limited ($18.85 billion of which 49% was North America), and Bristol-Myers Squibb Company ($22.56 billion of which 100% was BioPharmaceuticals).

Sales Analysis. During the year ended December of 2018, sales at AstraZeneca PLC were $22.09 billion. This is a decrease of 1.7% versus 2017, when the company's sales were $22.47 billion.
  Stock Performance Chart for AstraZeneca PLC - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/10/2020): 49.85
(Figures in U.S. Dollars)
1 Week -0.5%   13 Weeks 3.1%  
4 Weeks 14.4%   52 Weeks 34.9%  
AstraZeneca PLC - ADR Key Data:
  Ticker: AZN Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 22,090,083,942
(Year Ending Jan 2019).
Employees: 64,400
  Currency: U.S. Dollars Market Cap: 130,784,778,260
  Fiscal Yr Ends: December Shares Outstanding: 2,623,566,264
  Share Type: Ordinary Closely Held Shares: 9,183,372
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.